is part of the Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Reverdia now licensing its Biosuccinium technology

Bio-succinic acid producer Reverdia, a joint venture between DSM and Roquette, is now licensing its Biosuccinium technology for companies who want to integrate bio-succinic acid production into their business offerings. President of Reverdia Marcel Lubben made the announcement today at the European Forum for Industrial Biotechnology (EFIB).

Biosuccinium is a non-fossil feedstock derived chemical building block that enables the production of competitive bio-based materials with a lower eco-footprint for use in applications ranging from packaging to footwear. It is a building block for the production of polymers and chemicals, including bioplastic polybutylene succinate (PBS), resins for paints and coatings, phthalate-free plasticizers and polyester polyols for polyurethanes. Reverdia's low pH yeast fermentation process has best-in-class carbon performance as demonstrated by the published cradle-to-gate LCA by the University of Utrecht. Moreover, this proprietary yeast technology has fewer unit operations, is energy-efficient and generates less waste and impurities than bacteria-based alternatives.

Since December 2012, Reverdia has been producing its succinic acid from renewable resources at its dedicated plant in Cassano Spinola, Italy. The 10,000 metric tons/yr plant was the first commercial facility to use low-pH yeast technology to enable the production of a high quality, environmentally friendly product. Now, however, next to selling directly to customers, the company is taking the further step of licensing the technology in order to stimulate interest in and the use of biosuccinnic acid.

As Marcel Lubben pointed out on making the announcement: "By licensing the Biosuccinium technology as well as selling product direct, we are ensuring that more customers can benefit from Reverdia's experience in technology and application development. The licensing offering is essential to unlock the bio-based market and is the next logical step in our evolution."

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish